Gene therapy and kidney diseases

Area of Science:

• Nephrology
• Genetics
• Biotechnology

Background:

• Chronic kidney disease (CKD) is a major global health issue, predicted to be a leading cause of death by 2040.
• Existing treatments for CKD focus on managing symptoms and slowing disease progression, not addressing underlying genetic causes.
• Advances in understanding kidney disease genomics and cell-specific gene therapy have created new therapeutic possibilities.

Purpose of the Study:

• To review the potential of gene therapy and genome editing for treating kidney diseases.
• To explore various delivery routes and systems for targeting specific kidney cells.
• To discuss how gene therapy can be applied to enhance kidney health.

Main Methods:

• Review of current scientific literature on gene therapy and genome editing in the context of kidney diseases.
• Analysis of different delivery strategies for targeting renal cells.
• Examination of the application of gene therapy for improving kidney function and health.

Main Results:

• Gene therapy and genome editing show significant promise as personalized treatments for kidney diseases.
• Various delivery systems are being developed to effectively target specific kidney cells.
• Successful application of these technologies could revolutionize kidney disease management.

Conclusions:

• Targeting disease-causing genes through gene therapy represents a paradigm shift in treating chronic kidney disease.
• Further research into efficient and safe delivery methods is crucial for clinical translation.
• Gene therapy holds the potential to offer curative or significantly improved outcomes for patients with kidney disease.